BIOMAT Database Logo BIOMAT Database Logo

[Biological availability of hydroxydial (Ipronal "Polfa")]. 1982

M Gamski, and J Lewandowska, and L Falkowski

UI MeSH Term Description Entries
D011277 Pregnanediones Pregnane derivatives in which two side-chain methyl groups or two methylene groups in the ring skeleton (or a combination thereof) have been oxidized to keto groups. Diketopregnanes,Dioxopregnanes
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities

Related Publications

M Gamski, and J Lewandowska, and L Falkowski
[Comparative evaluation of biological availability and anti-arrhythmia effectiveness of Mexicard (mexiletine Polfa)].
January 1989, Kardiologia polska,
M Gamski, and J Lewandowska, and L Falkowski
[Studies on the effects of ipronal "Polfa" on the reactivity of the cutaneous blood vessels].
April 1966, Polski tygodnik lekarski (Warsaw, Poland : 1960),
M Gamski, and J Lewandowska, and L Falkowski
[Evaluation of biological availability and anti-arrhythmic effect of a new drug Phenytoinum "Polfa"].
January 1990, Polski tygodnik lekarski (Warsaw, Poland : 1960),
M Gamski, and J Lewandowska, and L Falkowski
[CLINICAL OBSERVATIONS ON THE USE OF THE D1H PREPARATION (IPRONAL "POLFA") IN THE TREATMENT OF NEUROSES].
March 1963, Polski tygodnik lekarski (Warsaw, Poland : 1960),
M Gamski, and J Lewandowska, and L Falkowski
[Evaluation of the relative biological availability of amiodarone Polfa preparation after extravascular administration of a single dose].
January 1989, Kardiologia polska,
M Gamski, and J Lewandowska, and L Falkowski
[Studies of the biological availability of phenytoin preparations (Polfa) and micronized phenytoin in patients with cardiac rhythm disorders].
January 1987, Kardiologia polska,
M Gamski, and J Lewandowska, and L Falkowski
[Studies on the effect of ipronal "Polfa" on the state of neurosecretion of hypothalamic nuclei and neurohypophysis in guinea pigs overloaded with fluids].
January 1969, Endokrynologia Polska,
M Gamski, and J Lewandowska, and L Falkowski
[Biological availability].
July 1975, Arzneimittel-Forschung,
M Gamski, and J Lewandowska, and L Falkowski
[Evaluation of biological equivalency of Sustonit (Polfa) and Sustac by plethysmography].
January 1989, Acta poloniae pharmaceutica,
M Gamski, and J Lewandowska, and L Falkowski
Biological availability of fluoride.
September 1970, The Journal of nutrition,
Copied contents to your clipboard!